Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Singlre Arm, Open Label Study on the Safety and Efficacy of Neoantigen Tumor Vaccine in Advanced Gastric Cancer

NCT05227378 is registered in ClinicalTrials.gov with Shen Lin as lead sponsor.

NCT NCT05227378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05227378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Singlre Arm, Open Label Study on the Safety and Efficacy of Neoantigen Tumor Vaccine in Advanced Gastric Cancer
Lead sponsor
Shen Lin
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2022
Completion date
August 31, 2025
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer